3 completed, 1 unknown. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 3, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
Follow testosterone undecanoate: new trials by email Literature Review of testosterone undecanoate trials Research Report on testosterone undecanoate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17 Relugolix 120Mg Tab, Curcumin, Testosterone Undecanoate 237 MG Oral Capsule - Hypogonadism, Male | Phase 1 / Phase 2 | Unknown | University of Washington | 10 | 2024-06-01 | 2024-03-15 |
| Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes Testosterone Undecanoate - Hypogonadism, Male | Phase 1 | Completed | Clarus Therapeutics, Inc. | 13 | 2018-07-15 | 2019-07-09 |
| Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism DITEST, Testosterone undecanoate - Male Hypogonadism | Phase 1 | Completed | Neurocrine UK Limited | 25 | 2016-11-03 | 2026-09-14 |
| Phlebotomy Study of Testosterone Undecanoate Oral Testosterone Undecanoate - Hypogonadism | Phase 1 / Phase 2 | Completed | Clarus Therapeutics, Inc. | 8 | 2016-01-01 | 2018-03-09 |
Eunuchism (3) · Hypogonadism (3) · Neoplasm Metastasis (1)
Clarus Therapeutics, Inc. (2) · Neurocrine UK Limited (1) · University of Washington (1)
United States (2) · United Kingdom (1)
Christina Wang, M.D. (1) · J Newell-Price, MA, PhD (1) · John Amory, MD (1)